NVS-CECR2-1

CAT: 0013-GTR19244066-01Size: 100 mgDry Ice: NoHazardous: No

1 / 1

CAT#:0013-GTR19244066-01Size:100 mg

Selected

24/48H Stock Items & 2 to 6 Weeks non Stock Items.

Quick Request Actions

Description

NVS-CECR2-1, a non-BET family Bromodomain (BRD) inhibitor, is a potent and selective cat eye syndrome chromosome region, candidate 2 (CECR2) inhibitor. NVS-CECR2-1 binds to CECR2 BRD with high affinity (IC50=47 nM; KD=80 nM) . NVS-CECR2-1 exhibits cytotoxic activity and induces apoptosis against various cancer cells by targeting CECR2 as well as via CECR2-independent mechanism.

CAS Number

1992047-61-6

Field of Research

Epigenetics & Chromatin

Purity

>98% (HPLC)

Solubility

In Vitro: DMSO : 66.67 mg/mL (134.50 mM; Ultrasonic)

Smiles

O=S (=O) (C1=NC (=CC (=N1) C2=CC=C3C (C=CN3C4CC (NC (C) (C) C4) (C) C) =C2) NC5CC5) CCC

Molecular Formula

C27H37N5O2S

Molecular Weight

495.68

Storage Conditions

Storage temperature: -20°C. Stability: ≥ 2 years

Notes

For research use only.

Related Products

Catalog	Name
GTR19234863-01	NVS-BPTF-1
GTR19174746-01	NVS-PAK1-1
GTR19186635-01	NVS-BET-1
GTR19155915-01	NVS-PAK1-1
GTR19205270-01	NVS-CRF38
GTR19234255-01	NVS-STG2
GTR19212265-01	NVS-MALT1
GTR19193274-01	NVS-SM2
GTR19222048	NVS PAK1 C
GTR19191739	NVS-PAK1-C

Alternative Products

Catalog	Name
BN163669-01	NVS-CECR2-1
A24385-50	NVS-CECR2-1 50mg
A24385-10	NVS-CECR2-1 10mg
A24385-100	NVS-CECR2-1 100mg
A24385-5	NVS-CECR2-1 5mg
5744/10	NVS-CECR2-1 10 mg
5744/50	NVS-CECR2-1 50 mg
BA4352-5	NVS-PAK1-1
HY-126299-01	NVS-BPTF-1
7482/10	NVS MLLT-1

NVS-CECR2-1

Related Products

Alternative Products

Popular Products